Neimeth International Pharmaceuticals Plc.

(NSE:NEIMETH) active

SECTOR & INDUSTRY
Healthcare Pharmaceuticals
Connect
My Recommendation

Add a New Recommendation

COMPETITORS
LAST CLOSE
LAST Volume Sold
1 Month Return
Market Cap


HISTORICAL STOCK DATA
DATE OPEN HIGH LOW CLOSE % CHG VOLUME
2018-06-22 0.58 0.58 0.57 0.57 -5.0 465894
2018-06-21 0.6 0.6 0.6 0.6 0.0 682911
2018-06-20 0.0 0.0 0.0 0.6 0.0 15071
2018-06-19 0.6 0.6 0.6 0.6 0.0 1642102
2018-06-14 0.6 0.6 0.6 0.6 -4.76 2127595
2018-06-13 0.6 0.63 0.6 0.63 -4.76 1304800
2018-06-12 0.63 0.63 0.63 0.63 0.0 1245208
2018-06-11 0.63 0.63 0.63 0.63 0.0 1053372
2018-06-08 0.63 0.63 0.63 0.63 -4.55 955170
2018-06-07 0.66 0.66 0.66 0.66 0.0 1072050
Neimeth International Pharmaceuticals Plc a Nigerian based pharmaceutical company which is involved in manufacturing and marketing of pharmaceutical and animal health products. It is also involved in the production of animal enhancing medicaments.
NAME POSITION
Dr. (Mrs) E. I. Ekpunobi CEO
Dr. A. B. C Orjiako Chair
Mr. Christopher U. Mmeje Board Member
Mazi Sam I. Ohuabunwa Board Member
Engr. Godwin E. Omene Board Member
Mr. Godfrey N. Ohuabunwa Board Member
Mr. A.O Balogun Board Member
Prof. Elijah N. Sokomba Board Member
Professor Maurice M. Iwu Board Member
Thomas Tunbosun Osubu Board Member
Phar. Sir. Ike Onyechi Board Member


BALANCE SHEET (All Currency in NGN)
Year Total Assets Total Liabilities Total Cash Total Debt/Equity
FY 2016 2688.73 M 1466.31 M 566.85 M 1078.21 M
FY 2015 2200.24 M 1042.92 M 77.32 M 584.22 M
FY 2014 2782.49 M 1289.48 M 63.42 M 638.83 M
FY 2013 2891.08 M 1110.87 M 83.22 M 499.34 M
INCOME STATEMENT (All Currency in NGN)
Year Total Revenue Cost of Revenue Net Income Gross Profit/Loss EBITDA
FY 2016 2001.82 M 787.34 M 65.09 M 1214.48 M 468.52 M
FY 2015 1460.73 M 786.66 M -335.68 M 674.07 M -86.48 M
FY 2014 1628.40 M 886.46 M -228.54 M 741.94 M -56.59 M
FY 2013 2016.52 M 977.19 M 130.58 M 1039.33 M 244.79 M

Period End: March 31, 2017


Balance Sheet (All Currency in NGN)

Total Assets: 2557.72 M
Total Liabilities: 1530.55 M
Total Cash: 208.09 M
Total Debt: 1149.00 M

Income Statement (All Currency in NGN)

Revenue: 464.03 M
Cost of Revenue: 157.18 M
Net Income: 53.12 M
Gross Profit/Loss: 306.85 M
EBITDA: 94.53 M

COMPANY DOCUMENTS

Financial Statements
Annual Reports


VALUATION MEASURES
MKT CAP P/E RATIO EPS
1674.71M 0.04 24.25
SIMPLE MOVING AVERAGES (SMA)
DATE 10-DAY MA 20-DAY MA 50-DAY MA 100-DAY MA
2018-06-22 0.62 0.64 0.73 0.8
2018-06-21 0.62 0.65 0.73 0.8
2018-06-20 0.63 0.65 0.74 0.8
2018-06-19 0.64 0.66 0.74 0.8
2018-06-14 0.64 0.67 0.75 0.8
INDICATORS
DATE RSI MACD BB
2018-06-22 0.71 -0.04 0.52
2018-06-21 1.01 -0.04 0.5
2018-06-20 1.01 -0.05 0.49
2018-06-19 1.01 -0.05 0.48
2018-06-14 1.01 -0.05 0.47

Neimeth International Pharmaceuticals Plc. (NEIMETH)   ·   0.57 | -5.0%

My Recommendations
ENTRY DATE TARGET VALUE TARGET DATE RECOMMENDATION
You haven't added any recommendations yet

My Notes
You have not created any notes yet